CapsoVision (CV) Shares Outstanding (Weighted Average) (2024 - 2025)

CapsoVision's (CV) quarterly Shares Outstanding (Weighted Average) came in at $24.6 million in Q4 2025, up 1115.57% year-on-year from $2.0 million in Q4 2024, and down 46.87% quarter-over-quarter from $46.2 million in Q3 2025.

CapsoVision (CV) Shares Outstanding (Weighted Average) (2024 - 2025) Analysis & Trends

CapsoVision has disclosed Shares Outstanding (Weighted Average) across 2 years of filings, most recently posting $24.6 million for Q4 2025.

  • Shares Outstanding (Weighted Average) for Q4 2025 came in at $24.6 million, up 1115.57% year-over-year; the trailing twelve-month figure through Dec 2025 was $24.6 million (up 1115.57% YoY), and the FY2025 annual result was $24.6 million, up 1115.57% from the prior year.
  • Shares Outstanding (Weighted Average) came in at $24.6 million for Q4 2025 at CapsoVision, down from $46.2 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $46.2 million in Q3 2025 to a low of $2.0 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 1.74 Bn
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 382.90 Mn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 1.28 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 1.48 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 579.20 Mn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 456.00 Mn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 385.10 Mn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 98.20 Mn
10 CapsoVision 176.55 Mn 166.44 Mn 1.95 Mn 24.56 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 24.56 Mn
Sep 30, 2025 46.22 Mn
Jun 30, 2025 2.23 Mn
Dec 31, 2024 2.02 Mn
Sep 30, 2024 1.99 Mn
Jun 30, 2024 1.96 Mn